Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

withdrawn133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

NCT02458079
completedphase_3

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

NCT00561093
withdrawnnot_applicable

Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography

NCT01144091

Clinical Trials (3)

Showing 3 of 3 trials
NCT02458079Not Applicable

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

Completed
NCT00561093Phase 3

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

Completed
NCT01144091Not Applicable

Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3